Mood and Anxiety Related Phenotypes in Mice

Understanding behavioral regulation can further progress by developing new approaches that allow refinement of behavioral phenotypes. The current availability of several thousand different mutant mice and of human candidate genes for emotional (affective) disorders challenges behavioral neuroscientists to extend their views and methodologies to dissect complex behaviors into behavioral phenotypes and subsequently to define gene–behavioral phenotype relationships. Here, we put forward multiday automated behavioral and physiological observations in carefully designed environments to assess evolutionary conserved behavioral strategies in mice. This offers the opportunity to design experimental setups that allow the animals themselves to regulate their own behavior, using representations of continuous kinematic variables, studying the dynamics of behavior (change across time or change across activity); i.e., growth or decay processes of behavior and concomitant physiological adjustments such as heart rate. The measures characterizing these processes should have discriminative power (across strains or treatments) and be replicable (across laboratories). Furthermore, cross species genetic studies for these neurobehavioral and physiological traits may provide a novel way toward identifying neurobiological mechanisms underlying core features of complex psychiatric disorders.

[1]  S. Alonso,et al.  Sex differences in behavioral despair: Relationships between behavioral despair and open field activity , 1991, Physiology & Behavior.

[2]  R. Lister,et al.  Effect of isolation on brain monoamines and the behavior of mice in tests of exploration, locomotion, anxiety and behavioral ‘despair’ , 1989, Pharmacology Biochemistry and Behavior.

[3]  F. Liu,et al.  WAY-200070, a selective agonist of estrogen receptor beta as a potential novel anxiolytic/antidepressant agent , 2008, Neuropharmacology.

[4]  O. Puciłowski,et al.  Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression , 1995, Psychopharmacology.

[5]  D. Murphy,et al.  Evaluation of Antidepressant-related Behavioral Responses in Mice Lacking the Serotonin Transporter , 2002, Neuropsychopharmacology.

[6]  C. Beyer,et al.  Angiotensin IV elevates oxytocin levels in the rat amygdala and produces anxiolytic-like activity through subsequent oxytocin receptor activation , 2010, Psychopharmacology.

[7]  Alan A. Wilson,et al.  Bupropion occupancy of the dopamine transporter is low during clinical treatment , 2002, Psychopharmacology.

[8]  R. Andreatini,et al.  Animal models: Trait or state measure? The test-retest reliability of the elevated plus-maze and behavioral despair , 2000, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[9]  S. Kayaalp,et al.  Effect of changes in swimming area on results of “behavioral despair test” , 1994, Pharmacology Biochemistry and Behavior.

[10]  M. Le Moal,et al.  Abolition and reversal of strain differences in behavioral responses to drugs of abuse after a brief experience. , 2000, Science.

[11]  M. Colombel,et al.  [Enhancement of nociceptive reactions by naloxone in mice and rats (author's transl)]. , 1974, Psychopharmacologia.

[12]  J. Besson,et al.  A reinvestigation of the analgesic effects induced by stimulation of the periaqueductal gray matter in the rat. I. The production of behavioral side effects together with analgesia , 1984, Brain Research.

[13]  Adrienne Z. Ables,et al.  Antidepressants: update on new agents and indications. , 2003, American family physician.

[14]  C. Nemeroff Anxiolytics: past, present, and future agents. , 2003, The Journal of clinical psychiatry.

[15]  M. Freedman,et al.  The effects of serotonin antagonists in a behavioral despair procedure in mice. , 1984, European journal of pharmacology.

[16]  F. Turek,et al.  The circadian Clock mutation increases exploratory activity and escape‐seeking behavior , 2003, Genes, brain, and behavior.

[17]  N. Moore,et al.  Animal models of depression: are there any? , 2003, Human psychopharmacology.

[18]  Brigitta B. Gundersen,et al.  Effects of Chronic Fluoxetine in Animal Models of Anxiety and Depression , 2004, Neuropsychopharmacology.

[19]  S. Nomura,et al.  A new behavioral test for antidepressant drugs. , 1982, European journal of pharmacology.

[20]  J. Crabbe,et al.  Genetics of mouse behavior: interactions with laboratory environment. , 1999, Science.

[21]  G. Koob,et al.  Cellular and Behavioral Interactions of Gabapentin with Alcohol Dependence , 2008, The Journal of Neuroscience.

[22]  M. Bourin,et al.  The effect of the potassium channel activator, cromakalim, on antidepressant drugs in the forced swimming test in mice , 1996, Fundamental & clinical pharmacology.

[23]  Cécile Béguin,et al.  Depressive-Like Effects of the κ-Opioid Receptor Agonist Salvinorin A on Behavior and Neurochemistry in Rats , 2006, Journal of Pharmacology and Experimental Therapeutics.

[24]  M. Vaswani,et al.  Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[25]  G. Griebel,et al.  4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II. Characterization in rodent models of stress-related , 2002, The Journal of pharmacology and experimental therapeutics.

[26]  M. Bourin,et al.  Involvement of 5-HT2C receptors in the anti-immobility effects of antidepressants in the forced swimming test in mice , 2001, European Neuropsychopharmacology.

[27]  C. Grillon,et al.  Morphine pretreatment reduces clomipramine effect in mouse forced-swimming test. , 1983, European journal of pharmacology.

[28]  M. Hascöet,et al.  Brain structures implicated in the four-plate test in naïve and experienced Swiss mice using injection of diazepam and the 5-HT2A agonist DOI , 2009, Behavioural Brain Research.

[29]  Michel Bourin,et al.  Forced swimming test in mice: a review of antidepressant activity , 2004, Psychopharmacology.

[30]  G. Woodruff,et al.  The behavioural properties of CI‐988, a selective cholecystokininB receptor antagonist , 1991, British journal of pharmacology.

[31]  R. Hen,et al.  Altered Emotional States in Knockout Mice Lacking 5-HT1A or 5-HT1B Receptors , 1999, Neuropsychopharmacology.

[32]  C. Bell,et al.  Tryptophan depletion and its implications for psychiatry , 2001, British Journal of Psychiatry.

[33]  A. Saria,et al.  Different behavioral profiles of the non-peptide substance P (NK1) antagonists CP-96,345 and RP 67580 in Swiss albino mice in the black-and-white box , 1993, Neuroscience Letters.

[34]  M. Millan,et al.  The neurobiology and control of anxious states , 2003, Progress in Neurobiology.

[35]  M. Bourin,et al.  Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity , 1998, Psychopharmacology.

[36]  G. Griebel 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. , 1995, Pharmacology & therapeutics.

[37]  A. M. Scotto di Tella,et al.  [Influence of the procedure of administration in the activity of some antidepressant or disinhibiting drugs upon behavioural despair (author's transl)]. , 1981, Journal de pharmacologie.

[38]  A. Rex,et al.  Effects of cholecystokinin tetrapeptide and sulfated cholecystokinin octapeptide in rat models of anxiety , 1994, Neuroscience Letters.

[39]  J. Kan,et al.  Pharmacological evaluation of minaprine dihydrochloride, a new psychotropic drug. , 1982, Arzneimittel-Forschung.

[40]  B. Roques,et al.  Opioid and CCK Systems in Anxiety and Reward , 1995 .

[41]  M. Hascöet,et al.  Anticonflict Effect of Alpidem as Compared with the Benzodiazepine Alprazolam in Rats , 1997, Pharmacology Biochemistry and Behavior.

[42]  M. Hascöet,et al.  Anxiolytic-Like Effects of Antidepressants After Acute Administration in a Four-Plate Test in Mice , 2000, Pharmacology Biochemistry and Behavior.

[43]  H. Westenberg,et al.  Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors , 2000, Acta psychiatrica Scandinavica. Supplementum.

[44]  G. Griebel Variability in the effects of 5-HT-related compounds in experimental models of anxiety: evidence for multiple mechanisms of 5-HT in anxiety or never ending story? , 1996, Polish journal of pharmacology.

[45]  A. Eschalier,et al.  Influence of naloxone on antidepressant drug effects in the forced swimming test in mice , 2004, Psychopharmacology.

[46]  R. Porsolt Animal Models of Depression: Utility for Transgenic Research , 2000, Reviews in the neurosciences.

[47]  D. Nutt,et al.  Invited review: the evolution of antidepressant mechanisms , 2004, Fundamental & clinical pharmacology.

[48]  M. Detke,et al.  Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth , 1995, Behavioural Brain Research.

[49]  R. Porsolt,et al.  Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. , 1979, European journal of pharmacology.

[50]  P. Mandel,et al.  Minaprine, a new drug with antidepressant properties. , 1985, Drugs under experimental and clinical research.

[51]  C. Kuo,et al.  Characterization of lamotrigine inhibition of Na+ channels in rat hippocampal neurones , 1997, British journal of pharmacology.

[52]  S. Stahl,et al.  Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders. , 2008, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[53]  J. Deakin,et al.  Effects of ritanserin on aversive classical conditioning in humans , 2005, Psychopharmacology.

[54]  M. Cador,et al.  Effects of morphine and naloxone on behaviour in the hot plate test: an ethopharmacological study in the rat , 2005, Psychopharmacology.

[55]  M. Hascöet,et al.  Evidence for the activity of lamotrigine at 5-HT(1A) receptors in the mouse forced swimming test. , 2005, Journal of psychiatry & neuroscience : JPN.

[56]  M. Bourin,et al.  Pharmacotherapy of anxious disorders , 2002, Human psychopharmacology.

[57]  M. Hascöet,et al.  Implication of 5-HT2 receptor subtypes in the mechanism of action of antidepressants in the four plates test , 2005, Psychopharmacology.

[58]  D. Sanger,et al.  The effects of NMDA antagonists on punished exploration in mice , 1991, Behavioural pharmacology.

[59]  R. Porsolt,et al.  "Behavioural despair" in rats and mice: strain differences and the effects of imipramine. , 1978, European journal of pharmacology.

[60]  D. David,et al.  Comparison of antidepressant activity in 4- and 40-week-old male mice in the forced swimming test: involvement of 5-HT1A and 5-HT1B receptors in old mice , 2001, Psychopharmacology.

[61]  C. Goodchild,et al.  gamma-Aminobutyric acidA receptors and spinally mediated antinociception in rats. , 1996, The Journal of pharmacology and experimental therapeutics.

[62]  M. Bourin,et al.  Clonidine as a sensitizing agent in the forced swimming test for revealing antidepressant activity. , 1991, Journal of psychiatry & neuroscience : JPN.

[63]  Victor H. Denenberg,et al.  A computer-aided procedure for measuring swim rotation , 1990, Physiology & Behavior.

[64]  J. Hyttel Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs) , 1994, International clinical psychopharmacology.

[65]  C. Beyer,et al.  Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon , 2007, Neuropeptides.

[66]  A. Wesołowska,et al.  Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression , 2007, Neuropharmacology.

[67]  R. Twyman,et al.  Barbiturate regulation of kinetic properties of the GABAA receptor channel of mouse spinal neurones in culture. , 1989, The Journal of physiology.

[68]  M. Eller,et al.  Anxiolytic effects of lamotrigine and JZP-4 in the elevated plus maze and in the four plate conflict test. , 2009, European journal of pharmacology.

[69]  W. A. Prado,et al.  An assessment of the antinociceptive and aversive effects of stimulating identified sites in the rat brain , 1985, Brain Research.

[70]  S. Kõks,et al.  Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies , 2001, Physiology & Behavior.

[71]  R. Post,et al.  Mechanisms of Action of Anticonvulsants in Affective Disorders: Comparisons with Lithium , 1992, Journal of clinical psychopharmacology.

[72]  J. Cryan,et al.  Selective activation of metabotropic G-protein-coupled glutamate 7 receptor elicits anxiolytic-like effects in mice by modulating GABAergic neurotransmission , 2008, Behavioural pharmacology.

[73]  I. Lucki Serotonin receptor specificity in anxiety disorders. , 1996, The Journal of clinical psychiatry.

[74]  M. Bourin,et al.  Evidence of the activity of lithium on 5-HT1B receptors in the mouse forced swimming test: comparison with carbamazepine and sodium valproate , 1998, European Neuropsychopharmacology.

[75]  K. Hole,et al.  Benzodiazepine-induced antagonism of opioid antinociception may be abolished by spinalization or blockade of the benzodiazepine receptor , 1990, Pharmacology Biochemistry and Behavior.

[76]  M. Hascöet,et al.  Anxiolytic-like effect of milnacipran in the four-plate test in mice: Mechanism of action , 2005, Pharmacology Biochemistry and Behavior.

[77]  M. Naoi,et al.  Effects of moclobemide on forced-swimming stress and brain monoamine levels in mice , 1996, Pharmacology Biochemistry and Behavior.

[78]  E. Mogilnicka,et al.  Dihydropyridine calcium channel antagonists reduce immobility in the mouse behavioral despair test; antidepressants facilitate nifedipine action. , 1987, European journal of pharmacology.

[79]  M. Bourin,et al.  Influence of Prior Experience on Mice Behavior Using the Four-Plate Test , 1997, Pharmacology Biochemistry and Behavior.

[80]  H. Iwata,et al.  In vivo characterization of T-794, a novel reversible inhibitor of monoamine oxidase-A, as an antidepressant with a wide safety margin. , 1998, The Journal of pharmacology and experimental therapeutics.

[81]  T. Umezu Effects of psychoactive drugs in the Vogel conflict test in mice. , 1999, Japanese journal of pharmacology.

[82]  S. Maier,et al.  Librium prevents the analgesia and shuttlebox escape deficit typically observed following inescapable shock , 1984, Pharmacology Biochemistry and Behavior.

[83]  M. Hascöet,et al.  Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety , 2003, Behavioural Brain Research.

[84]  S. Ikemoto,et al.  Social isolation effects on the “behavioral despair” forced swimming test: Effect of age and duration of testing , 1991, Physiology & Behavior.

[85]  S. Kulkarni,et al.  GABA-mediated modification of despair behavior in mice , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[86]  M. Bourin,et al.  Comparison of behavioral effects after single and repeated administrations of four benzodiazepines in three mice behavioral models. , 1992, Journal of psychiatry & neuroscience : JPN.

[87]  W. Pakulska,et al.  Effect of diazepam and midazolam on the antinociceptive effect of morphine, metamizol and indomethacin in mice. , 2001, Die Pharmazie.

[88]  R. Ring,et al.  Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications , 2006, Psychopharmacology.

[89]  G. Szymczyk,et al.  Influence of antiepileptics on efficacy of antidepressant drugs in forced swimming test. , 2000, Polish journal of pharmacology.

[90]  A. Wesołowska,et al.  Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression , 2006, Neuropharmacology.

[91]  B. Costall,et al.  Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[92]  C. Chopde,et al.  Behavioral action of ethanol in Porsolt’s forced swim test: modulation by 3alpha-hydroxy-5alpha-pregnan-20-one , 2002, Neuropharmacology.

[93]  G. Skuza,et al.  Pharmacological profile of milnacipran, a new antidepressant, given acutely. , 1999, Polish journal of pharmacology.

[94]  P. Rocca,et al.  Paroxetine efficacy in the treatment of generalized anxiety disorder , 1997, Acta psychiatrica Scandinavica.

[95]  J. Siuciak,et al.  Antidepressant-Like Effect of Brain-derived Neurotrophic Factor (BDNF) , 1997, Pharmacology Biochemistry and Behavior.

[96]  Y. Kiuchi,et al.  Antinociceptive efficacy of antidepressants: assessment of five antidepressants and four monoamine receptors in rats , 2001, Journal of Anesthesia.

[97]  Antonio Alcaro,et al.  Genotype- and experience-dependent susceptibility to depressive-like responses in the forced-swimming test , 2002, Psychopharmacology.

[98]  E. Tatarczyńska,et al.  The anxiolytic-like activity of AIDA (1-aminoindan-1,5-dicarboxylic acid), an mGLu 1 receptor antagonist. , 2004, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[99]  K. Chopra,et al.  Antidepressant activity of quercetin, a bioflavonoid, in streptozotocin-induced diabetic mice. , 2003, Journal of medicinal food.

[100]  E. F. Espejo,et al.  Structure of the rat's behaviour in the hot plate test , 1993, Behavioural Brain Research.

[101]  M. Volosin,et al.  Corticosterone influences forced swim-induced immobility , 1994, Pharmacology Biochemistry and Behavior.

[102]  R. Post,et al.  Antidepressant effects of carbamazepine. , 1986, The American journal of psychiatry.

[103]  M. Hascöet,et al.  The influence of buspirone, and its metabolite 1-PP, on the activity of paroxetine in the mouse light/dark paradigm and four plates test , 2000, Pharmacology Biochemistry and Behavior.

[104]  奥田 圭子 Trazodone hydrochloride attenuates thermal hyperalgesia in a chronic constriction injury rat model , 2002 .

[105]  E. Kiyatkin,et al.  Severe brain hypothermia as a factor underlying behavioral immobility during cold-water forced swim , 2003, Brain Research.

[106]  P. Skolnick,et al.  Intra- and interstrain differences in models of “behavioral despair” , 2001, Pharmacology Biochemistry and Behavior.

[107]  C. Beyer,et al.  Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders , 2008, Psychopharmacology.

[108]  Richard Graham Knowles,et al.  Inhibition by Lamotrigine of the Generation of Nitric Oxide in Rat Forebrain Slices , 1995, Journal of neurochemistry.

[109]  M. Hascöet,et al.  The four-plates test: Anxiolytic or analgesic paradigm? , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[110]  M. Bourin,et al.  Differential effects of clonidine, lithium and quinine in the forced swimming test in mice for antidepressants: possible roles of serotoninergic systems , 1996, European Neuropsychopharmacology.

[111]  S. Schreiber,et al.  The antinociceptive effect of trazodone in mice is mediated through both μ-opioid and serotonergic mechanisms , 2000, Behavioural Brain Research.

[112]  Andrzej Pilc,et al.  Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models , 1999, Neuropharmacology.

[113]  M. Barrot,et al.  Essential role of brain-derived neurotrophic factor in adult hippocampal function. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[114]  I. Lucki,et al.  Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs. , 2001, The Journal of pharmacology and experimental therapeutics.

[115]  M. Hascöet,et al.  Effect of noradrenergic system on the anxiolytic-like effect of DOI (5-HT2A/2C agonists) in the four-plate test , 2005, Psychopharmacology.

[116]  M. Bourin,et al.  A schematic representation of the psychopharmacological profile of antidepressants , 1996, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[117]  M. Bourin,et al.  Antidepressant-like effect of lamotrigine is reversed by veratrine: A possible role of sodium channels in bipolar depression , 2008, Behavioural Brain Research.

[118]  D. David,et al.  Antidepressant-like effects in various mice strains in the forced swimming test , 2003, Psychopharmacology.

[119]  M. Bourin Is it possible to predict the activity of a new antidepressant in animals with simple psychopharmacological tests? , 1990, Fundamental & clinical pharmacology.

[120]  Takeo Yoshikawa,et al.  Identification of multiple genetic loci linked to the propensity for "behavioral despair" in mice. , 2002, Genome research.

[121]  M. Hascöet,et al.  The four-plates test–retest paradigm to discriminate anxiolytic effects , 2005, Psychopharmacology.

[122]  Jan Passchier,et al.  Visualisation of serotonin-1A (5-HT1A) receptors in the central nervous system , 2001, European Journal of Nuclear Medicine.

[123]  E. Przegaliński,et al.  Anxiolytic- and antidepressant-like effects of an antagonist at glycineB receptors. , 1998, Polish journal of pharmacology.

[124]  M. Hascöet,et al.  Implication of 5-HT2A subtype receptors in DOI activity in the four-plates test–retest paradigm in mice , 2006, Behavioural Brain Research.

[125]  Douglas Wahlsten,et al.  Different data from different labs: lessons from studies of gene-environment interaction. , 2003, Journal of neurobiology.

[126]  F. Borsini,et al.  The effect of DAU 6215, a novel 5HT-3 antagonist, in animal models of anxiety. , 1993, Pharmacological research.

[127]  T. Hata,et al.  Behavioral characteristics of SART-Stressed mice in the forced swim test and drug action , 1995, Pharmacology Biochemistry and Behavior.

[128]  J. Gorman,et al.  SSRIs and SNRIs: broad spectrum of efficacy beyond major depression. , 1999, The Journal of clinical psychiatry.

[129]  W. Chance,et al.  Non-specificity of "behavioral despair" as an animal model of depression. , 1979, European journal of pharmacology.

[130]  A. Eschalier,et al.  Naloxone inhibits clomipramine in mouse forced swimming test. , 1982, European journal of pharmacology.

[131]  M. Hascöet,et al.  α2-Adrenergic agonists antagonise the anxiolytic-like effect of antidepressants in the four-plate test in mice , 2005, Behavioural Brain Research.

[132]  N. Cosford,et al.  Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABA(A) signaling. , 2004, Neuropharmacology.

[133]  J. Feighner Overview of antidepressants currently used to treat anxiety disorders. , 1999, The Journal of clinical psychiatry.

[134]  M. Bourin,et al.  How valuable are animal models in defining antidepressant activity? , 2001, Human psychopharmacology.

[135]  M. Kołaczkowski,et al.  Synthesis and pharmacological evaluation of new 5-(cyclo)alkyl-5-phenyl- and 5-spiroimidazolidine-2,4-dione derivatives. Novel 5-HT1A receptor agonist with potential antidepressant and anxiolytic activity. , 2010, European journal of medicinal chemistry.

[136]  M. P. McDonald,et al.  The alpha(2a)-adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety. , 2001, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[137]  I. Lucki The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. , 1997, Behavioural pharmacology.

[138]  M. Rutkowska,et al.  Effects of Cannabinoids on the Anxiety-like Response in Mice , 2022 .

[139]  G. Perrault,et al.  A Comparative Study of the Effects of Selective and Non-Selective 5-HT2 Receptor Subtype Antagonists in Rat and Mouse Models of Anxiety , 1997, Neuropharmacology.

[140]  T. Feuerstein,et al.  Effects of gabapentin on release of gamma-aminobutyric acid from slices of rat neostriatum. , 1993, Arzneimittel-Forschung.

[141]  J. Kocsis,et al.  A summary of mechanistic hypotheses of gabapentin pharmacology , 1998, Epilepsy Research.

[142]  I. Lucki,et al.  Increasing the Levels of Insulin-Like Growth Factor-I by an IGF Binding Protein Inhibitor Produces Anxiolytic and Antidepressant-Like Effects , 2007, Neuropsychopharmacology.

[143]  F. Gasparini,et al.  Potential anxiolytic‐ and antidepressant‐like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist , 2001, British journal of pharmacology.

[144]  Ronald G. Browne Effects of antidepressants and anticholinergics in a mouse "behavioral despair" test. , 1979, European journal of pharmacology.

[145]  M. Hascöet,et al.  Additive effects of lithium and antidepressants in the forced swimming test: further evidence for involvement of the serotoninergic system , 1994, Psychopharmacology.

[146]  I. Lucki,et al.  Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice , 2001, Psychopharmacology.

[147]  M. Barrot,et al.  Brain-derived neurotrophic factor in the ventral midbrain–nucleus accumbens pathway: a role in depression , 2003, Biological Psychiatry.

[148]  T. Krahe,et al.  Effects of rotational side preferences on immobile behavior of normal mice in the forced swimming test , 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[149]  M. Dubocovich,et al.  Antidepressant-like activity of the melatonin receptor antagonist, luzindole (N-0774), in the mouse behavioral despair test. , 1990, European journal of pharmacology.

[150]  Philip S. Portoghese,et al.  Antidepressant-Like Effects of κ-Opioid Receptor Antagonists in the Forced Swim Test in Rats , 2003, Journal of Pharmacology and Experimental Therapeutics.

[151]  T. Gould,et al.  The behavioral actions of lithium in rodent models: Leads to develop novel therapeutics , 2007, Neuroscience & Biobehavioral Reviews.

[152]  M. Corsi,et al.  Effects of antidepressant drugs and GR 205171, an neurokinin-1 (NK1) receptor antagonist, on the response in the forced swim test and on monoamine extracellular levels in the frontal cortex of the mouse , 2003, Neuroscience Letters.

[153]  Chieh-fu Chen,et al.  Anxiolytic-like effects of baicalein and baicalin in the Vogel conflict test in mice. , 2003, European journal of pharmacology.

[154]  S. Kulkarni,et al.  Anti-depressant action of melatonin in chronic forced swimming-induced behavioral despair in mice, role of peripheral benzodiazepine receptor modulation , 2000, European Neuropsychopharmacology.

[155]  R. Porsolt,et al.  Behavioral despair in mice: a primary screening test for antidepressants. , 1977, Archives internationales de pharmacodynamie et de therapie.

[156]  M. Hascöet,et al.  Evaluation of efficacies of different classes of antidepressants in the forced swimming test in mice at different ages , 1998, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[157]  P. Jolliet,et al.  Evidence for a 5-HT2A receptor mode of action in the anxiolytic-like properties of DOI in mice , 2003, Behavioural Brain Research.

[158]  S. Maier,et al.  Opioid and nonopioid interactions in two forms of stress-induced analgesia , 1993, Pharmacology Biochemistry and Behavior.

[159]  B. Costall,et al.  The selective sigma2-ligand Lu 28-179 has potent anxiolytic-like effects in rodents. , 1997, The Journal of pharmacology and experimental therapeutics.

[160]  P. Simon,et al.  A new method for rapid screening of minor tranquillizers in mice. , 1968, European journal of pharmacology.

[161]  D. David,et al.  Antidepressant-like effects in various mice strains in the tail suspension test , 2003, Behavioural Brain Research.

[162]  G. MacQueen,et al.  Performance of heterozygous brain-derived neurotrophic factor knockout mice on behavioral analogues of anxiety, nociception, and depression. , 2001, Behavioral neuroscience.

[163]  S. Hunskaar,et al.  Antinociceptive effects of serotonergic reuptake inhibitors in mice , 1989, Neuropharmacology.

[164]  I. Paul,et al.  Group housing of mice increases immobility and antidepressant sensitivity in the forced swim and tail suspension tests. , 2001, European journal of pharmacology.

[165]  S. Cabib,et al.  The contribution of comparative studies in inbred strains of mice to the understanding of the hyperactive phenotype , 2002, Behavioural Brain Research.

[166]  E. Gould,et al.  Preclinical models: status of basic research in depression , 2002, Biological Psychiatry.

[167]  A. West Neurobehavioral studies of forced swimming: The role of learning and memory in the forced swim test , 1990, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[168]  M. Briley,et al.  Psychopharmacology of midalcipran, 1-phenyl-1-diethyl-amino-carbonyl-2-aminomethylcyclopropane hydrochloride (F 2207), a new potential antidepressant , 2004, Psychopharmacology.

[169]  P. Chopin,et al.  Animal models of anxiety: the effect of compounds that modify 5-HT neurotransmission , 1987 .

[170]  B. J. Cole,et al.  Comparison of several benzodiazepine receptor ligands in two models of anxiolytic activity in the mouse: an analysis based on fractional receptor occupancies , 1994, Psychopharmacology.

[171]  Y. Kitamura,et al.  Influence of ACTH on the effects of imipramine, desipramine and lithium on duration of immobility of rats in the forced swim test , 2002, Pharmacology Biochemistry and Behavior.

[172]  M. Hascöet,et al.  Anxiolytic-like effects of DOI microinjections into the hippocampus (but not the amygdala nor the PAG) in the mice four plates test , 2007, Behavioural Brain Research.

[173]  A. Meli,et al.  Is the forced swimming test a suitable model for revealing antidepressant activity? , 2004, Psychopharmacology.

[174]  A. Puech,et al.  Influence of anxiolytic drugs on the effects of specific serotonin reuptake inhibitors in the forced swimming test in mice , 1997, Journal of psychopharmacology.

[175]  B. Cooper,et al.  Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo. , 1980, The Journal of pharmacology and experimental therapeutics.

[176]  S. Otomo,et al.  Decreased body temperature dependent appearance of behavioral despair in the forced swimming test in mice. , 2000, Pharmacological research.

[177]  G. Wegener,et al.  Increased extracellular serotonin level in rat hippocampus induced by chronic citalopram is augmented by subchronic lithium: neurochemical and behavioural studies in the rat , 2003, Psychopharmacology.

[178]  G. Sills The mechanisms of action of gabapentin and pregabalin. , 2006, Current opinion in pharmacology.

[179]  S. Woods,et al.  Serotonin function in anxiety , 1987, Psychopharmacology.